Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C I Coleman

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Practice|September 23, 2009
Understanding heterogeneity in meta-analysis: the role of meta-regressionW L Baker, C Michael White, J C Cappelleri, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 18, 2018
Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysisC I Coleman, T J Bunz, D Eriksson, et al.
International Journal of Clinical Practice|July 29, 2015
Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetesW J Saulsberry, C I Coleman, E S Mearns, et al.
International Journal of Clinical Practice|November 19, 2011
Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillationC I Coleman, D M Sobieraj, S Winkler, et al.
Journal of Internal Medicine|October 17, 2006
The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac deathN N Henyan, C M White, E L Gillespie, et al.
International Journal of Clinical Practice|May 12, 2010
Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysisC I Coleman, L A Tuttle, C Teevan, et al.
International Journal of Clinical Practice|September 22, 2012
Factors associated with 'caregiver burden' for atrial fibrillation patientsC I Coleman, S M Coleman, J Vanderpoel, et al.
International Journal of Clinical Practice|November 18, 2015
External validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) multivariable prediction ruleC G Kohn, W F Peacock, G J Fermann, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 25, 2015
Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysisE S Mearns, W J Saulsberry, C M White, et al.
Journal of Thrombosis and Haemostasis : JTH|March 31, 2015
Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trialsE S Mearns, C I Coleman, D Patel, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Practice|September 23, 2009
Understanding heterogeneity in meta-analysis: the role of meta-regressionW L Baker, C Michael White, J C Cappelleri, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 18, 2018
Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysisC I Coleman, T J Bunz, D Eriksson, et al.
International Journal of Clinical Practice|July 29, 2015
Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetesW J Saulsberry, C I Coleman, E S Mearns, et al.
International Journal of Clinical Practice|November 19, 2011
Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillationC I Coleman, D M Sobieraj, S Winkler, et al.
Journal of Internal Medicine|October 17, 2006
The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac deathN N Henyan, C M White, E L Gillespie, et al.
International Journal of Clinical Practice|May 12, 2010
Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysisC I Coleman, L A Tuttle, C Teevan, et al.
International Journal of Clinical Practice|September 22, 2012
Factors associated with 'caregiver burden' for atrial fibrillation patientsC I Coleman, S M Coleman, J Vanderpoel, et al.
International Journal of Clinical Practice|November 18, 2015
External validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) multivariable prediction ruleC G Kohn, W F Peacock, G J Fermann, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 25, 2015
Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysisE S Mearns, W J Saulsberry, C M White, et al.
Journal of Thrombosis and Haemostasis : JTH|March 31, 2015
Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trialsE S Mearns, C I Coleman, D Patel, et al.
Pageof 3